Peptide Conjugated Lipid Nanoparticles for Anti-Cancer Drug Delivery

Abstract

Peptide Conjugated Lipid Nanoparticles and their role on Cancer Drug Delivery are reviewed here. The benefits of nanotechnology and combination style of medicine delivery are still hindered without the active ligands needed for treatment efficacy. This work analyzes the role of peptide ligands in different forms of cancer treatments targeting cells and tissues. Keyword: Peptide-conjugated lipid nanoparticles, nanotechnology, angiogenesis, anti-angiogenesis, lung cancer, breast cancer Article Info: Received 10 Jan 2019; Review Completed 02 Feb 2019; Accepted 08 Feb 2019; Available online 15 Feb 2019 Cite this article as: Xiao W, Peptide Conjugated Lipid Nanoparticles for Anti-Cancer Drug Delivery, Journal of Drug Delivery and Therapeutics. 2019; 9(1-s):374-376 http://dx.doi.org/10.22270/jddt.v9i1-s.2331 *Address for Correspondence: Wei Xiao, State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co. Ltd., Lianyungang, 222001, China